Pharmaceutical Technology
Pharmaceutical Technology in the Department of Pharmacy and Pharmaceutical Sciences focuses on the design, engineering, and translation of advanced drug delivery systems that address unmet clinical and industrial needs. The domain embraces a multidisciplinary and highly translational research culture, combining pharmaceutical formulation science with nanotechnology, biomaterials, pharmaceutical engineering, and immuno-oncology delivery platforms.
Core strengths lie in the formulation and delivery of small molecules, peptides, biologics, and nucleic-acid–based therapeutics, with expertise on nano- and biohybrid- carriers, and smart biomaterials. Research activities are tightly integrated with mechanistic pharmacology, immunology, and disease biology, enabling rational design of delivery systems that enhance efficacy, safety, and patient outcomes.
Faculty in Pharmaceutical Technology have established internationally competitive innovation pipelines, supported by strong industry engagement and a proven track record in patents, invention disclosures, and spin-off–ready technologies. Key research areas include:
- Advanced delivery systems for small molecule, ADC, peptide, protein, and nucleic acid therapeutics, including cancer vaccines and immunotherapies
- Bioinspired and cell-derived delivery platforms and pharmaceutical biomaterials
- Topical, transdermal, and localized delivery technologies
- Antimicrobial formulations and peptide-based biomaterials for wound healing, antibiofilm formation and tissue repair
- Pharmaceutical engineering and scalable processing strategies supporting manufacturability and clinical translation
Collectively, Pharmaceutical Technology in the Department functions as a translational engine that integrates formulation science, process engineering, and disease biology to enable rational product design, scalable manufacturing, and efficient clinical and commercial deployment of next‑generation therapeutics. Ultimately, the goal is to transform novel ideas into clinically acceptable products.
